Evidence map›Paper›PMID 32190728›Full record

ArticleChemistrySelect2019

Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis.

Carol B Hanna, Shan Yao, Mat Martin, Ernst Schönbrunn, Gunda I Georg, Jeffrey T Jensen, Rebecca A D Cuellar

Open access · hybridAbstract read
In one paragraph

Article in ChemistrySelect, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Non-Hormonal Contraception.Journal of clinical medicine · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carol B HannaDivision of Reproductive & Developmental Sciences, Oregon National Primate Research Center, 505 Northwest 185 Avenue, Beaverton, OR 97006 (USA).
Shan YaoDivision of Reproductive & Developmental Sciences, Oregon National Primate Research Center, 505 Northwest 185 Avenue, Beaverton, OR 97006 (USA).
Mat MartinDrug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, 12902 USF Magnolia Drive, Tampa, FL 33612 (USA).
Ernst SchönbrunnDrug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, 12902 USF Magnolia Drive, Tampa, FL 33612 (USA).
Gunda I GeorgDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, University of Minnesota, 717 Delaware Street Southeast, Minneapolis, MN 55414 (USA).
Jeffrey T JensenDivision of Reproductive & Developmental Sciences, Oregon National Primate Research Center, 505 Northwest 185 Avenue, Beaverton, OR 97006 (USA).
Rebecca A D CuellarDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, University of Minnesota, 717 Delaware Street Southeast, Minneapolis, MN 55414 (USA).
Oregon National Primate Research Center · USMoffitt Cancer Center · USUniversity of Minnesota · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Nonhuman Primate Contraceptive CoreU54HD055744 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STOUFFER, RICHARD L · 2007 to 2016
$13.8M
Drug Discovery & Synthesis of Contraceptive AgentsU01HD076542 · NICHD · UNIVERSITY OF MINNESOTA · PI GEORG, GUNDA I. · 2012 to 2016
$5.0M
NCI NIH HHS P30 CA076292NICHD NIH HHS U01 HD076542NICHD NIH HHS U54 HD055744NIH HHS P51 OD011092
6 · The paper itself

Abstract

We used a progressive elimination strategy to identify oocyte-specific WEE2 kinase inhibitors for potential non-hormonal contraceptives that target meiosis. Beginning with an in-house library of over 300,000 compounds, virtual high throughput screening identified 57 WEE2 inhibitors with preferential predicted binding over the somatic variant WEE1. Seven compounds were further evaluated

Indexed as

Cell cycleInhibitorMeiosisOocyteWEE kinase

Identifiers

PMID32190728
PMCPMC7079731
OpenAlexW2993695038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.